Importance of Bcl-2-targeted therapies
John Gribben et al.
Side-effect of idelalisib and its use in chronic lymphocytic leukemia
Overview of a Phase I clinical trial using BGB-3111 for the treatment of relapsed CLL
Measuring treatment response rates in multiple myeloma
COMFORT-II clinical trial: the 5 yr results